If you need to come back to us and tell Congress that the FDA's mission is to fine tune narrowly just around the approval process rather than being proactive to deal with an issue that is as massive as the management of pain, I hope you will come back to us and tell us that because I would think we would need to.
Kaine emphasizes the need for the FDA to adopt a proactive approach to pain management.
Share
More from Tim Kaine
Many Virginians want to age with dignity in their homes, where they can remain connected with their family, friends, and community.
I’m thrilled that $16 million is headed to the Virginia Advanced Pharma Manufacturing Cluster to support the domestic manufacturing of critical medicines, boost our supply chains, and grow our regional economy.
This is a pivotal moment in the Ukrainian people’s fight to protect their freedom.
Other voices in this conversation
